WallStreetZenWallStreetZen

NASDAQ: AUPH
Aurinia Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for AUPH

Based on 3 analysts offering 12 month price targets for Aurinia Pharmaceuticals Inc

Min Forecast
$15.00-2.28%
Avg Forecast
$17.33+12.92%
Max Forecast
$21.00+36.81%

Should I buy or sell AUPH stock?

Based on 3 analysts offering ratings for Aurinia Pharmaceuticals Inc.

Buy
Strong Buy
1 analysts 33.33%
Buy
0 analysts 0%
Hold
2 analysts 66.67%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Strong Buy" agrees with analyst consensus with a "Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their AUPH stock forecasts and price targets.

AUPH stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-12-03
lockedlocked$00.00+00.00%2025-11-07
lockedlocked$00.00+00.00%2025-11-05

1 of 1

Forecast return on equity

Is AUPH forecast to generate an efficient return?

Company
21.35%
Industry
62.54%
Market
166.28%
AUPH's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is AUPH forecast to generate an efficient return on assets?

Company
16.51%
Industry
30.53%
AUPH is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

AUPH earnings per share forecast

What is AUPH's earnings per share in the next 3 years based on estimates from 8 analysts?

Avg 1 year Forecast
$0.81-62.25%
Avg 2 year Forecast
$1.07-50.05%
Avg 3 year Forecast
$1.32-38.2%
AUPH's earnings are forecast to... subscribe to Premium to read more.
Forecast High Earnings Growth Forecast

AUPH revenue forecast

What is AUPH's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$332.7M+17.54%
Avg 2 year Forecast
$385.1M+36.05%
Avg 3 year Forecast
$448.0M+58.27%
AUPH's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

AUPH earnings growth forecast

How is AUPH forecast to perform vs Biotechnology companies and vs the US market?

Company
-14.79%
Industry
10.83%
Market
34.37%
AUPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Industry Forecast
AUPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Market Forecast
AUPH's earnings are forecast to... subscribe to Premium to read more.
Forecast Earnings Growth vs Savings Rate Forecast

AUPH revenue growth forecast

How is AUPH forecast to perform vs Biotechnology companies and vs the US market?

Company
16.54%
Industry
36.44%
Market
14.06%
AUPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
AUPH's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

AUPH vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
AUPH$15.35$17.33+12.92%Buy
OCUL$9.43$22.00+133.30%Strong Buy
MESO$15.74N/AN/A
ZYME$26.61$43.00+61.59%Strong Buy
STOK$33.08$43.14+30.42%Strong Buy
View Top Biotech Stocks

Aurinia Pharmaceuticals Stock Forecast FAQ

Is Aurinia Pharmaceuticals Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: AUPH) stock is to Buy AUPH stock.

Out of 3 analysts, 1 (33.33%) are recommending AUPH as a Strong Buy, 0 (0%) are recommending AUPH as a Buy, 2 (66.67%) are recommending AUPH as a Hold, 0 (0%) are recommending AUPH as a Sell, and 0 (0%) are recommending AUPH as a Strong Sell.

If you're new to stock investing, here's how to buy Aurinia Pharmaceuticals stock.

What is AUPH's earnings growth forecast for 2026-2028?

(NASDAQ: AUPH) Aurinia Pharmaceuticals's forecast annual earnings growth rate of -14.79% is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 10.83%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 34.37%.

Aurinia Pharmaceuticals's earnings in 2026 is $287,202,000.On average, 8 Wall Street analysts forecast AUPH's earnings for 2026 to be $107,413,957, with the lowest AUPH earnings forecast at $88,611,860, and the highest AUPH earnings forecast at $129,846,161. On average, 8 Wall Street analysts forecast AUPH's earnings for 2027 to be $142,145,977, with the lowest AUPH earnings forecast at $72,974,473, and the highest AUPH earnings forecast at $219,202,659.

In 2028, AUPH is forecast to generate $175,867,417 in earnings, with the lowest earnings forecast at $62,549,549 and the highest earnings forecast at $294,597,204.

What is AUPH's revenue growth forecast for 2026-2028?

(NASDAQ: AUPH) Aurinia Pharmaceuticals's forecast annual revenue growth rate of 16.54% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 36.44%, and while it is forecast to beat the US market's average forecast revenue growth rate of 14.06%.

Aurinia Pharmaceuticals's revenue in 2026 is $283,055,000.On average, 9 Wall Street analysts forecast AUPH's revenue for 2026 to be $44,240,774,423, with the lowest AUPH revenue forecast at $41,699,699,014, and the highest AUPH revenue forecast at $47,959,972,706. On average, 9 Wall Street analysts forecast AUPH's revenue for 2027 to be $51,205,794,303, with the lowest AUPH revenue forecast at $46,912,161,391, and the highest AUPH revenue forecast at $63,588,051,868.

In 2028, AUPH is forecast to generate $59,569,668,882 in revenue, with the lowest revenue forecast at $51,473,065,971 and the highest revenue forecast at $78,170,979,135.

What is AUPH's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: AUPH) forecast ROA is 16.51%, which is lower than the forecast US Biotechnology industry average of 30.53%.

What is AUPH's Price Target?

According to 3 Wall Street analysts that have issued a 1 year AUPH price target, the average AUPH price target is $17.33, with the highest AUPH stock price forecast at $21.00 and the lowest AUPH stock price forecast at $15.00.

On average, Wall Street analysts predict that Aurinia Pharmaceuticals's share price could reach $17.33 by Dec 3, 2026. The average Aurinia Pharmaceuticals stock price prediction forecasts a potential upside of 12.92% from the current AUPH share price of $15.35.

What is AUPH's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: AUPH) Aurinia Pharmaceuticals's current Earnings Per Share (EPS) is $2.14. On average, analysts forecast that AUPH's EPS will be $0.81 for 2026, with the lowest EPS forecast at $0.67, and the highest EPS forecast at $0.98. On average, analysts forecast that AUPH's EPS will be $1.07 for 2027, with the lowest EPS forecast at $0.55, and the highest EPS forecast at $1.65. In 2028, AUPH's EPS is forecast to hit $1.32 (min: $0.47, max: $2.22).

What is AUPH's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: AUPH) forecast ROE is 21.35%, which is considered strong.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.